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Abstract
Background: Although aberrant protamine (PRM) ratios have been observed in infertile 
men, the mechanisms that implicit the uncoupling of PRM1 and PRM2 expression remain 
unclear. To uncover these mechanisms, in this observational study we have compared the 
PRM1/PRM2 mRNA ratio and mRNA contents of two regulatory factors of these genes. 
Materials and Methods: In this experimental study, sampling was performed by a mul-
ti-step method from 50 non-obstructive azoospermic and 12 normal men. After RNA 
extraction and cDNA synthesis, real-time quantitative polymerase chain reaction (RT-
QPCR) was used to analyze the PRM1, PRM2, Y box binding protein 2 (YBX2) and 
JmjC-containing histone demethylase 2a (JHDM2A) genes in testicular biopsies of the 
studied samples.
Results: The PRM1/PRM2 mRNA ratio differed significantly among studied groups, 
namely 0.21 ± 0.13 in azoospermic samples and -0.8 ± 0.22 in fertile samples. The amount 
of PRM2 mRNA, significantly reduced in azoospermic patients. Azoospermic men exhib-
ited significant under expression of YBX2 gene compared to controls (P<0.001). mRNA 
content of this gene showed a positive correlation with PRM mRNA ratio (R=0.6, P=0.007). 
JHDM2A gene expression ratio did not show any significant difference between the studied 
groups (P=0.3). We also observed no correlation between JHDM2A mRNA content and the 
PRM mRNA ratio (R=0.2, P=0.3). 
Conclusion: We found significant correlation between the aberrant PRM ratio (PRM2 
under expression) and lower YBX2 mRNA content in testicular biopsies of azoospermic 
men compared to controls, which suggested that downregulation of the YBX2 gene might 
be involved in PRM2 under expression. These molecules could be useful biomarkers for 
predicting male infertility.     
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Introduction 
Protamines (PRMs) comprise the largest amount of 
nucleoproteins in mature human sperm. These pro-
teins are transcribed in steps 1-4 of spermatids (1) 
while synthesis of the corresponding proteins starts, 
with temporal delay, in step 4 spermatids (2). During 
spermiogenesis, PRMs replace somatic histones in a 
step-by-step manner, and cause higher DNA packag-
ing in sperm compared to somatic cells. On the other 
hand, the condensed and insoluble nature of the sperm 
chromatin protects the genetic integrity of the parental 
genome during its transport through the male and fe-
male reproductive tracts (3).
Various studies reported abnormal expressions 
of PRM genes in sperm of infertile men. In addition, 
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correlation of the altered PRM1/PRM2 ratio has been 
shown with low sperm counts, decreased sperm mo-
tility and morphology, decreased fertilization ability 
and increased sperm chromatin damage (4-7). Several 
factors have been postulated and studied as possible 
causes of PRM1/PRM2 deregulation (8-11). One of 
these candidate mechanisms is PRM gene polymor-
phisms that have also been reported for PRM1, 2 
genes. However most of these studies suggest that 
none of the PRMs’ single nucleotide polymorphisms 
(SNPs) and transition protein genes is likely to be a 
common cause of PRM abnormalities. Other factors 
that have attracted attention in this regard are tran-
scription and translation regulatory genes of PRM. 
Several genes and proteins involved in PRM1/PRM2 
expression regulation have been identified and pre-
sented (12-16); until now, modification of these fac-
tors in infertile men with PRM deficiency attracted 
less attention. In this study we have proposed two 
PRM regulatory factors -Y box binding protein 2 
(YBX2) gene and JmjC-containing histone demethy-
lase 2a (JHDM2A) gene. These genes encode two 
important proteins involved in regulation of PRM1/
PRM2 expressions (17, 18). YBX2 is the human hom-
ologue of Xenopus DNA/RNA-binding and mouse 
MSY2 proteins (16), animal model studies show that 
this protein exists abundantly in testis tissue and is ex-
pressed in meiotic and post-meiotic germ cells (17). 
YBX2 acts as an mRNA stabilizer and a transcription 
factor of PRM genes (18, 19). Consequently, YBX2 
loss of expression is likely to contribute to the nuclear 
condensation defects that occur in Msy2-null late-
stage spermatids (20). JHDM2A specifically regulates 
the expression of genes that encode transition protein 
1 (Tnp1) and PRM1; this is necessary for proper chro-
matin reorganization during spermatid maturation by 
directly promoting transcription of TNP1 and PRM1 
genes (21). The current study analyzes the PRMs ratio 
in testicular tissue of azoospermic men. As YBX2 and 
JHDM2A are involved in expression regulation of 
these genes, we have additionally evaluated whether 
PRM deficiency is related to downregulation of these 
genes.
Materials and Methods
Testicular tissue
This experimental study was approved by the 
Ethical Committee of the Faculty of Medical 
Sciences of Qazvin Medical Science Univer-
sity (Qazvin, Iran). After patients gave their in-
formed written consent, testicular biopsies were 
obtained from 50 infertile men with a mean 
age of 31.3 ± 3.7 years; these patients were 
candidates for assisted reproductive technique 
(ART) and exhibited impaired spermatogenesis. 
In 12 patients with obstructive azoospermia af-
ter vasectomy, biopsies were performed out for 
diagnostic reasons during vasectomy reversal. 
These biopsies revealed normal spermatogenesis 
which served as controls; the mean age of these 
individuals was 35 ± 2.9 years. In this study pa-
tients were excluded if they had the following 
criteria: Y chromosome microdeletion, cystic 
fibrosis, varicocele, Klinefelter syndrome, or 
exposure to chemotherapy and radiation. In non-
obstructive azoospermia patients, one part of the 
testicular tissue specimen was used for testicular 
sperm extraction, while the other part was cut into 
two pieces. One piece was immediately prepared 
and frozen for the RNA extraction procedure and 
the other piece was fixed in Bouin’s fixative, then 
embedded in paraffin.
Histological evaluation
We stained 5 µm paraffin sections in hematox-
ylin and eosin, and then scored the sections ac-
cording to the modified Johnsen scoring system 
for histological evaluation (22). In this system of 
classification, all tubular sections in each piece of 
the testicular biopsy are evaluated systematically, 
and each is given a score from 1 to 10. Complete 
spermatogenesis with numerous spermatozoa is 
evaluated as score 10; slightly impaired spermato-
genesis, numerous late spermatids, disorganized 
epithelium as score 9, less than five spermatozoa 
per tubule and few late spermatids as score 8, no 
spermatozoa, no late spermatids, and numerous 
early spermatids as score 7, no spermatozoa, no 
late spermatids, and few early spermatids as score 
6; no spermatozoa or spermatids, and many sper-
matocytes as score 5, no spermatozoa or sperma-
tids, and few spermatocytes as score 4; spermato-
gonia only as score 3, no germinal cells and Sertoli 
cells only as score 2; no seminiferous epithelium 
as score 1 (11). To follow this classification 
method, we divided the samples into two groups 
based on the above scoring: normal spermatogen-
esis (scores 9-10) and impaired spermatogenesis 
(scores 1-8) (Table 1, Fig.1A-E). It should be men-
tioned that our samples with score 8 had severe 
hypospermatogenesis. 
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Table 1: Characterization of patient candidates for ICSI
P valueAzoospermic menFertile men
31.3 ± 3.735 ± 2.9Age (Y) (Mean ± SD)
1-810Histology  (Score)
14.26 ± 7.35.2 ± 2.3Serum FSH (mIU/ml) (Mean ± SD)
<0.00010.21 ± 0.13-0.8 ± 0.22ΔCt (PRM2-PRM1), (Mean ± SD)
<0.00015.1 ± 1.23.3 ± 0.99ΔCt (YBX2-GAPDH), (Mean ± SD)
0.56.3 ± 0.896.1 ± 1.1ΔCt (JHDM2A-GAPDH), (Mean ± SD)
FSH; Follicle stimulating hormone and ICSI; Intracytoplasmic sperm injection. 
Fig.1:  Results of hematoxylin and eosin staining  of testis tissues. A. Hypospermatogenesis, B. Maturation arrest in round spermatid stage, 
C. Maturation arrest in spermatocyte stage, D. Maturation arrest in spermatogonial stage and E. Sertoli cell only. (magnification: ×1000).
A
C
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D
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RNA extraction and first strand cDNA synthesis
After homogenizing frozen testis tissues using an 
Ultrasonic Processor UP100H (Hielsher, Germany), 
RNA was extracted with an RNeasy Mini Kit (Qia-
gene, Germany). The extracted RNA was frozen at 
-80˚C. We used a Nano Drop 2000c (Thermo, USA) 
to evaluate the quantity of isolated total RNAs. In 
this regard, RNA samples with A260/A280 ratios 
of >2 were selected for quantitative analysis. First 
strand complementary DNA (cDNA) synthesis was 
also performed using the Revert Aid First Strand 
cDNA Synthesis Kit (Thermo Scientific, Fermentas, 
Waltham, MA, USA).
Real time quantitative polymerase chain reac-
tion (RT-QPCR)
We designed four target genes primers and 
probes (PRM1, 2, YBX2 and JHDM2A) using 
Gene Runner Softw are (Version 3.05, Table 2). 
A Taq Man RT- QPCR assay was carried out in 
final reaction volumes of 20 µl with 10 µl of Taq 
Man Master Mix (Takara, Shiga, Japan), 0.2 μM 
of forward and reverse primers, and 2 μl of cDNA. 
Thermal cycling was performed on the ABI-7500 
(Applied Biosystems, Foster, CA, USA) sequence 
detection system by using the following cycling 
condition: 30 seconds at 95˚C as the first dena-
turation step, followed by 40 cycles at 95˚C for 5 
seconds and 60˚C for 34 seconds. Each assay was 
repeated at least twice. The log-ratio of the tran-
script content in the samples was determined 
by the ΔCt method of relative quantification. 
The log-ratio of PRM1 and PRM2 was also cal-
culated by ΔCt = CtPRM2 – CtPRM1, for YBX2 and 
JHDM2A, these were ΔCt= CtYBX2 – CtGAPDH  and 
ΔCt= CtJHDM2A – CtGAPDH. To study the correlation 
between YBX2 and JHDM2A mRNA content and 
PRM log concentration, we used the calculating 
pattern of Steger et al. (6). Since Ct of PRM1 did 
not change in the different groups, log-concen-
tration of YBX2 and JHDM2A were normalized 
to PRM1 (ΔCt= CtYBX2 – CtPRM1 and ΔCt= CtJHDM2A 
– CtPRM1) (23).
Table 2: Primer and probe sequences of target and internal control genes
Amplicon size (bp)SequenceTarget and internal control  genes
124F: TGACTCACAGCCCACAGAGT PRM1
R: CTGCGACAGCATCTGTACCT
P:AGGCCAAGCCCATCCTGCAC
98F:GCAAGAGCAAGGACACCACPRM2
R:GACACTGCTCTCGAAGGAGG
P: CGGAGCACGTCGAGGTCT
150F:CCCTACCCAGTACCCTGCTYBX2
R:CCTTCCTTCAACCCTTGATAA
P:CAGGAGGACCAAAGCAGCAGC
145F:  GTTCCACAAGCATTGACTGGJHDM2A
R :CTGGTGCATTTGAAACATCC
P:TGCCAATCCTCCTGAACTGCAG
93F: TCAAGAAGGTGGTGAAGCAG                             GAPDH
R:CGCTGTTGAAGTCAGAGGAG
P: CCTCAAGGGCATCCTGGGCT
YBX2; Y box binding protein 2, JHDM2A; JmjC-containing histone demethylase 2a, PRM; Protamin and GAPDH; Glyceraldehyde 3-phos-
phate dehydrogenase.
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Statistical analysis
In order to determine the significant differ-
ences between the studied groups, statistical 
analysis that included mean, standard deviation 
(SD), correlation coefficients (R2) and unpaired 
t test were performed with Prism (version 3) 
software. Additionally, linear correlations were 
tested using the Pearson coefficient of correla-
tion. All tests were performed at a confidence 
level of 95%.
Results
The mean Ct of PRM1 in testis tissues were 
almost identical, 23.4 ± 3.6 (azoospermic) and 
23.3 ± 1.5 (fertile). The mean Ct of PRM2 in 
azoospermic men was 23.6 ± 1.8 and in the fer-
tile group, it was 22.5 ± 0.41. Hence the expres-
sion ratio of PRM2 was lower than the PRM1 
expression ratio in azoospermic men. The loga-
rithm of the PRM1/PRM2 mRNA ratio in azo-
ospermic men was 0.21 ± 0.13 and for fertile 
men, it was -0.8 ± 0.22. This difference of ratios 
between fertile and azoospermic men was sta-
tistically significant (P<0.0001, Table 2).
In testicular tissues of azoospermic men with 
impaired spermatogenesis, the fold change of 
YBX2 transcripts was 0.02 ± 0.019, and the log 
ratio of YBX2 expression between azoospermic 
(5.1 ± 1.2) and fertile men (3.3 ± 0.99) signifi-
cantly differed (P<0.0001, Table 2).  In terms 
of JHDM2A gene expression, the differences of 
expression ratio were 6.1 ± 1.1 (fertile) and 6.3 
± 0.89 (azoospermic), which was not significant 
(P=0.5, Table 2 ).
The YBX2 mRNA content revealed a positive 
linear correlation (R=0.6, P=0.007) with the 
PRM1/PRM2 mRNA ratio or with PRM2 defi-
ciency (Fig.2A). However, we observed no lin-
ear correlation between JHDM2A mRNA con-
tent and the PRM1/PRM2 mRNA ratio (R=0.2, 
P=0.3, Fig.2B).
Fig.2: A. Correlation between the protamine-1 (PRM1) to PRM2 log-ratio ∆Ct (PRM2-PRM1) and normalized YBX2 log-concentration 
∆Ct(YBX2-PRM1, R=0.6, P=0.007) and B. Correlation between the PRM1 to PRM2 log-ratio ∆Ct (PRM2-PRM1) and normalized Jhdm2a 
log-concentration ∆Ct (JH-PRM1, R=0.2, P=0.3).
A B
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Discussion
In this research we observed a significant dif-
ference in PRM1/PRM2 ratio between azoosper-
mic and fertile men testicular biopsies (0.21 ± 
0.13, -0.8 ± 0.22). PRM2 changes were more than 
PRM1, which suggested different mRNA stabili-
ties for the two molecules. A variety of studies 
reported a relationship between abnormal PRM1/
PRM2 ratios and male infertility (4-6, 21, 23). On 
the basis of the studies which showed high PRM1/
PRM2 ratios, it has been supposed that a reduction 
in PRM2 expressions was responsible for aberrant 
PRM1/PRM2 ratios in infertile males. Along this 
line, two studies reported complete selective ab-
sence of PRM2 in infertile men (4, 24, 25). Lewis 
et al. (26) observed that in sperm of infertile men, 
PRM2 downregulation occurred much more fre-
quently than PRM1 deregulation, because PRM2 
expression was more sensitive to the variation of 
regulatory controlling mechanisms than those for 
PRM1.
Our results confirmed the results from the above 
studies; we have observed significant downregu-
lation of PRM2 in the studied azoospermic men. 
PRMs genes are only transcribed in round sperma-
tids and stored as silent mRNAs for later transla-
tion in elongating spermatids, in which transcrip-
tion is no longer active. Since it is well justified to 
consider altered PRMs mRNA levels as a potential 
origin of altered protein levels (1, 11, 27), we have 
evaluated PRM expression at the mRNA level. 
Generally speaking, the mechanisms that underlie 
the uncoupling of PRM1 and PRM2 expression re-
main unclear, but generally four pathways in regu-
lation of PRM gene expression have received more 
attention: the PRM genes themselves, transcription 
regulation, translation regulation, and downstream 
protein processing.
The PRM1 and PRM2 genes exist in a single 
chromatin domain in human sperm, and their tran-
scription is regulated by the same upstream regu-
latory elements, thus making transcriptional and 
translational regulation a possible cause for aber-
rant PRM1/PRM2 expression (28, 29). There are 
a number of regulatory proteins identified which 
are involved in repression or activation of PRM 
expression (29). In this regard, various animal 
models and in vitro studies have been performed, 
but scientists emphasize that future investigations 
should focus on aberrant expression, activation, 
and function of these regulatory factors in patients 
with deregulated PRM1/PRM2 ratios (30, 31). To 
this end, we have focused on the expression ratio 
of two factors of PRM gene expressions.
YBX2 is a transcription and translation regulato-
ry factor, and a germ-cell-specific molecule essen-
tial for the production of functional spermatozoa. 
This gene is expressed in meiotic and post-meiot-
ic germ cells, but its functional form is in round 
spermatids. Inactivation of YBX2 can lead to male 
infertility. YBX2, also known as Contrin, is the hu-
man homologue of Xenopus DNA/RNA-binding 
and mouse MSY2 proteins (32, 33). To clarify the 
functional role of MSY2 in germ cells, Yang et al. 
(19) have generated Msy2-null mice. They found 
that mutant males had an abnormally high num-
bers of apoptotic meiotic spermatocytes, lacked 
spermatozoa in the epididymis, and were sterile. 
Their results emphasized the major role of this 
protein in male fertility (33). Hammoud et al. 
(34) investigated YBX2 gene alterations in men 
with severe defects in spermatogenesis that in-
cluded azoospermia, severe oligozoospermia, 
and PRM deregulation samples. Their results 
showed 15 polymorphic sites, of which 7 poly-
morphisms were present at a statistically higher 
frequency in patients with infertility, particular-
ly in men with abnormal PRM expression. On 
the same path they showed that some SNPs in 
the YBX2 gene occurred at a significantly high-
er incidence in men with PRM abnormalities 
than the control group. Our results, accordingly, 
showed significant downregulation of this gene 
in testicular tissues of azoospermic men com-
pared to fertile men.
In terms of the molecular function of this pro-
tein, animal models and in vitro assay studies have 
shown that MSY2 acts as a transcription factor and 
an mRNA stabilizer which regulates expression 
of some testis specific genes at the transcription 
and translation levels, such as PRM1, 2. MSY2 
marks specific mRNAs (those transcribed from 
Y-box promoters) in the nucleus for cytoplasmic 
storage, and thereby links mRNA transcription 
and storage/translational delay. In this process, 
MSY2 recognizes the CTG ATTGGC/TC/TAA se-
quence, a DNA motif in the promoter of numerous 
genes specifically expressed in male germ cells. 
After binding MSY2 to its consensus promoter 
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sequence, it binds to transcripts of this gene, and 
stabilizes and represses their translation in cyto-
plasmic RNA-protein complexes (19, 35-38). 
Since PRM1, 2 are regulated by the same upstream 
regulatory elements, we have expected significant 
under expression of YBX2 to cause simultaneous 
downregulation of PRM1, 2 in our azoospermic 
samples compared to fertile samples.
Unlike our expectation PRM2 downregulated in 
the studied samples. We observed a positive lin-
ear correlation between downregulation of PRM2 
and YBX2 genes. Statistically, R=0.6 exhibited 
an intermediate or good correlation, but this cor-
relation was not perfect or 100%. This probably 
indicated that factors other than YBX2 were in-
volved in PRM2 downregulation. Consistent with 
our results, one study has shown that decreased 
PRM1 protein level is usually linked with post-
translational deregulation, but decreased PRM2 
is associated with low PRM2 mRNA (30). PRM2 
transcripts are more susceptible to variations other 
than PRM1 transcripts, downregulation of YBX2 
affects PRM2 transcripts more than PRM1 (26).
Another regulatory factor studied in this research 
was JHDM2A, also known as Jmjd1a or Kdm3a, 
was identified as an H3K9 demethylase (for mon-
omethylation and dimethylation). JHDM2A was 
originally cloned as a testis-specific gene tran-
script. Results of immune histochemical analysis 
using anti- JHDM2A antibody showed an intense 
nuclear expression of this gene in round spermatids 
and a sub-nuclear distribution. Co-expression of 
JHDM2A gene with RNA polymerase II indicated 
that JHDM2A might contribute to transcriptional 
activation of some testis specific genes. JHDM2A 
has been shown to stimulate the transcriptional ac-
tivation of transition nuclear protein1 and PRM1 
genes by bonding to the core promoter and remov-
ing H3K9 methylation (21). Histone demethylase 
JHDM2A is critical for Tnp1 and PRM2 transcrip-
tion and spermatogenesis. JHDM2A -deficient 
mice have infertility and smaller testes.
Despite the fact that animal model studies show 
the role of this protein in male infertility, we have 
not observed any significant difference in expres-
sion ratio of this gene between azoospermic and 
fertile men samples. Probably the role of this gene 
is not very influential in human spermatogenesis, 
and more samples must be studied. Regarding 
the correlation between this gene expression and 
PRM2 downregulation our results have shown no 
positive linear correlation. Statistically, shows a 
weak or no correlation. Other studies have shown 
that this gene acts as a transcriptional activator of 
the PRM1 gene. In addition, our samples displayed 
downregulation of the PRM2 gene; therefore, ex-
pression of JHDM2A in our samples did not have 
an important role.
Conclusion
We found significantly aberrant PRM mRNA ra-
tios and a lower YBX2 mRNA content in testicular 
spermatids of infertile men. In future studies the 
exact role of these molecules (YBX2 and JHDM2A) 
and other PRM expression regulatory factors must 
be determined in human spermatogenesis.
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